Nanomedicine has been emerging as a promising frontier for the treatment of inflammatory diseases, offering innovative approaches to enhance drug delivery and therapeutic outcomes. This chapter explores the pros and cons of nanomedicine strategies specifically tailored for targeting inflammatory conditions. On the positive side, nanocarriers enable targeted delivery of anti-inflammatory agents, minimizing off-target effects and enhancing drug bioavailability. Additionally, nanomedicine platforms provide opportunities for sustained release, prolonged circulation, and improved tissue penetration, addressing the challenges associated with conventional therapies. However, the use of nanomedicine in the context of inflammatory disorders is not without its challenges. Concerns such as biocompatibility, potential toxicity, and long-term safety implications necessitate careful consideration. This chapter critically evaluates recent advancements in nanomedicine for inflammatory diseases, shedding light on the potential benefits and drawbacks. It emphasizes the importance of a balanced perspective, taking into account the dual nature of nanomedicine, wherein its strengths can be harnessed for targeted therapy while actively mitigating associated risks. As the field continues to evolve, a nuanced understanding of the odds and evens of nanomedicine in inflammatory diseases is essential for guiding future research endeavours and ultimately advancing the translation of these innovative technologies into clinical practice.